| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpura. | Blood | 2005 | 1.37 |
| 2 | Differential cytokine and antibody responses to adult and larval stages of Onchocerca volvulus consistent with the development of concomitant immunity. | Infect Immun | 2002 | 0.87 |
| 3 | One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximab. | Pediatr Blood Cancer | 2009 | 0.84 |